Anixa Biosciences Inc (ANIX)

May 12, 2025

Anixa Biosciences Announces Poster Presentation on Ovarian Cance - GuruFocus

May 12, 2025

May 12, 2025

Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting - Stock Titan

May 12, 2025

May 09, 2025

Renaissance Technologies LLC Has $34,000 Stock Holdings in Anixa Biosciences, Inc. (NASDAQ:ANIX) - Defense World

May 09, 2025

May 01, 2025

Anixa Biosciences, Inc. (NASDAQ:ANIX) Shares Acquired by LPL Financial LLC - Defense World

May 01, 2025

Apr 30, 2025

Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual B - GuruFocus

Apr 30, 2025

Apr 30, 2025

Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th - Nasdaq

Apr 30, 2025

Apr 28, 2025

ANIX Gets New Patent for Breast Cancer Vaccine Technology, Stock Up - MSN

Apr 28, 2025

Apr 24, 2025

ANIXAnixa Biosciences Inc Latest Stock News & Market Updates - Stock Titan

Apr 24, 2025

Apr 18, 2025

Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Presented at the Rivkin Center & American Association of Cancer Research (AACR) 14th Biennial Ovarian Cancer Research Symposium - Seeking Alpha

Apr 18, 2025

Apr 15, 2025

Anixa Biosciences (ANIX) Secures Patent to Advance CAR-T Cancer Therapy | ANIX Stock News - GuruFocus

Apr 15, 2025

Apr 14, 2025

Anixa Biosciences Receives Notice of Allowance from U.S. Patent - GuruFocus

Apr 14, 2025

Apr 14, 2025

Anixa Biosciences- Receives Notice Of Allowance For Car-T Technology Patent - marketscreener.com

Apr 14, 2025

Apr 14, 2025

Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio | ANIX Stock News - GuruFocus

Apr 14, 2025

Apr 14, 2025

Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio - Finansavisen

Apr 14, 2025

Apr 13, 2025

Indo-Asian News Service - Indo-Asian News Service (IANS)

Apr 13, 2025

Apr 12, 2025

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting - marketscreener.com

Apr 12, 2025

Apr 12, 2025

Anixa Biosciences (NASDAQ:ANIX) Earns “Buy” Rating from D. Boral Capital - Defense World

Apr 12, 2025

Apr 11, 2025

Anixa Biosciences Stock Price, Quotes and Forecasts - Benzinga

Apr 11, 2025

Apr 11, 2025

Is AngioDynamics (ANGO) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Apr 11, 2025

Apr 10, 2025

Anixa gains US patent for breast cancer vaccine technology - Investing.com Australia

Apr 10, 2025

Apr 09, 2025

Anixa gains US patent for breast cancer vaccine technology By Investing.com - Investing.com Canada

Apr 09, 2025

Apr 09, 2025

Anixa Biosciences Shares Rise After Notice of Patent Allowance for Breast Cancer Vaccine - marketscreener.com

Apr 09, 2025

Apr 09, 2025

EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent - AOL.com

Apr 09, 2025

Apr 09, 2025

Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology - BioSpace

Apr 09, 2025

Apr 09, 2025

Anixa Biosciences stock rises on patent win (ANIX:NASDAQ) - Seeking Alpha

Apr 09, 2025

Apr 09, 2025

Anixa Biosciences Receives Notice Of Allowance From U.S. Patent And Trademark Office - MarketScreener

Apr 09, 2025

Apr 08, 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Apr 08, 2025

Apr 08, 2025

EF Hutton Initiates Coverage of Anixa Biosciences (ANIX) with Buy Recommendation - MSN

Apr 08, 2025

Apr 01, 2025

Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th - Quantisnow

Apr 01, 2025

Mar 28, 2025

Anixa Biosciences (NASDAQ:ANIX) Earns Buy Rating from D. Boral Capital - Defense World

Mar 28, 2025

Mar 27, 2025

What is HC Wainwright’s Forecast for ANIX Q1 Earnings? - Defense World

Mar 27, 2025

Mar 26, 2025

Anixa Biosciences’ (ANIX) Buy Rating Reaffirmed at HC Wainwright - Defense World

Mar 26, 2025

Mar 25, 2025

EXCLUSIVE: Anixa Biosciences Inks Letter of Intent with Austria-Based VERDI Solutions To Develop AI-Guided Personalized Cancer Vaccines - AOL.com

Mar 25, 2025

Mar 25, 2025

Anixa Enters Letter of Intent to Develop Verdi's AI-Guided Cancer Vaccines - MarketScreener

Mar 25, 2025

Mar 25, 2025

Anixa Biosciences Enters Letter of Intent with VERDI Solutions t - GuruFocus

Mar 25, 2025

Mar 25, 2025

VERDI Grants Anixa 6-month Right To Negotiate Transaction For Development Of VERDI's Cancer Vaccines - Nasdaq

Mar 25, 2025

Mar 25, 2025

Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines - Marketscreener.com

Mar 25, 2025

Mar 24, 2025

Anixa secures US patent for ovarian cancer vaccine tech By Investing.com - Investing.com Australia

Mar 24, 2025

Mar 24, 2025

EXCLUSIVE: Anixa Biosciences Poised To Receive US Patent For Ovarian Cancer Vaccine - AOL.com

Mar 24, 2025

Mar 24, 2025

Anixa secures US patent for ovarian cancer vaccine tech - Investing.com India

Mar 24, 2025

Mar 24, 2025

Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine - Marketscreener.com

Mar 24, 2025

Mar 23, 2025

Maxim Group Begins Coverage on Anixa Biosciences (NASDAQ:ANIX) - Defense World

Mar 23, 2025